These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25963076)

  • 1. Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical Practice.
    Kim B; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Gut Liver; 2015 Nov; 9(6):750-5. PubMed ID: 25963076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors for anemia among newly-diagnosed intestinal Behcet's disease patients.
    Ye JF; Chen Y; Cai JF; Shen Y; Zou J; Guan JL
    J Natl Med Assoc; 2019 Aug; 111(4):407-412. PubMed ID: 30803717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
    Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Outcomes of Emergency Room Visits in Intestinal Behçet's Disease.
    Park J; Cheon JH; Park Y; Park SJ; Kim TI; Kim WH
    Digestion; 2017 Nov; 96(4):231-238. PubMed ID: 29131059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease.
    Lee HJ; Kim YN; Jang HW; Jeon HH; Jung ES; Park SJ; Hong SP; Kim TI; Kim WH; Nam CM; Cheon JH
    World J Gastroenterol; 2012 Oct; 18(40):5771-8. PubMed ID: 23155319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.
    Lee HJ; Shin HS; Jang HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Yonsei Med J; 2014 Jul; 55(4):960-6. PubMed ID: 24954324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet's Disease.
    Park JW; Park Y; Park SJ; Kim TI; Kim WH; Cheon JH
    Gut Liver; 2018 Nov; 12(6):674-681. PubMed ID: 29938457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease.
    Cheon JH; Han DS; Park JY; Ye BD; Jung SA; Park YS; Kim YS; Kim JS; Nam CM; Kim YN; Yang SK; Kim WH;
    Inflamm Bowel Dis; 2011 Feb; 17(2):605-13. PubMed ID: 20848515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
    Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
    Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behçet's disease.
    Arimoto J; Endo H; Kato T; Umezawa S; Fuyuki A; Uchiyama S; Higurashi T; Ohkubo H; Nonaka T; Takeno M; Ishigatsubo Y; Sakai E; Matsuhashi N; Nakajima A
    Dig Endosc; 2016 Mar; 28(2):179-85. PubMed ID: 26459917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in the treatment of intestinal Behcet's disease.
    Ma D; Zhang CJ; Wang RP; Wang L; Yang H
    Cell Biochem Biophys; 2014 Jul; 69(3):735-9. PubMed ID: 24622940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
    Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
    Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease.
    Chung SH; Lee HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Gut Liver; 2016 Jul; 10(4):574-80. PubMed ID: 26780089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcomes and risk factors of early reoperation after initial intestinal resective surgery in patients with intestinal Behçet's disease.
    Park YE; Cheon JH; Park J; Lee JH; Lee HJ; Park SJ; Kim TI; Kim WH
    Int J Colorectal Dis; 2017 Apr; 32(4):591-594. PubMed ID: 28028614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of intestinal Behcet's disease during the first five years.
    Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
    Dig Dis Sci; 2013 Feb; 58(2):496-503. PubMed ID: 22899244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet's disease.
    Kang EA; Park JW; Park Y; Park SJ; Kim TI; Kim WH; Cho MS; Cheon JH
    BMC Gastroenterol; 2021 Oct; 21(1):362. PubMed ID: 34620099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.
    Park J; Cheon JH; Park YE; Lee YJ; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
    Int J Colorectal Dis; 2017 May; 32(5):745-751. PubMed ID: 27924367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.